Date Field | Doc. No. | Description (Pages) |
---|
Jul 21, 2017 | 30 | Notice of Report on the filing of an action regarding a Patent or Trademark. (c/m via cm/acf) (Attachments: # 1 Order) (Ortiz, Grisel) (Entered: 07/21/2017) (0) |
Jul 21, 2017 | N/A | Case transferred from New York Eastern has been opened in District of Delaware as case 1:17-cv-00992, filed 07/20/2017. (Florio, Lisa) (Entered: 07/21/2017) (0) |
Jul 19, 2017 | N/A | Case transferred to District of Delaware. Case Electronically Transfer. ALL FILINGS ARE TO BE MADE IN THE TRANSFER COURT, DO NOT DOCKET TO THIS CASE.. Ordered by Judge Joan M. Azrack on 7/19/2017. (Ortiz, Grisel) (Entered: 07/20/2017) (0) |
Jul 19, 2017 | 29 | ORDER granting 28 Motion to Change Venue: THE PARTIES HEREBY STIPULATE AND AGREE, subject to the approval of the Court, as follows: 1. This stay of this case is lifted. 2. The case shall be transferred from the Eastern District of New York to the District of Delaware. So Ordered by Judge Joan M. Azrack on 7/19/2017. (Ortiz, Grisel) (Entered: 07/20/2017) (3) |
Jul 7, 2017 | 28 | Letter MOTION to Change Venue by Amneal Pharmaceuticals Co. GmbH, Amneal Pharmaceuticals LLC. (Attachments: # 1 Stipulation and Proposed Order) (McQuillen, Brian) (Entered: 07/07/2017) (0) |
Apr 21, 2017 | 27 | WAIVER OF SERVICE Returned Executed by Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd.. Amneal Pharmaceuticals Co. GmbH waiver sent on 2/8/2017, answer due 5/9/2017. (Bennett, John) (Entered: 04/21/2017) (1) |
Mar 31, 2017 | N/A | Electronic ORDER granting 25 Motion for Leave to Appear Pro Hac Vice, Patrick Conlin Gallagher for Defendants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. GMBH. The attorney shall register for ECF, registration is available online at the NYEDs homepage. Once registered, the attorney shall file a notice of appearance and ensure that s/he receives electronic notification of activity in this case. Also, the attorney shall ensure that the $150 admission fee be submitted to the Clerks Office. So Ordered by Magistrate Judge Anne Y. Shields on 3/31/2017. (Casalini, Rosalinde) (Entered: 03/31/2017) (0) |
Mar 31, 2017 | N/A | Electronic ORDER granting 23 Motion for Leave to Appear Pro Hac Vice, Anthony J. Fitzpatrick for Defendants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. GMBH. The attorney shall register for ECF, registration is available online at the NYEDs homepage. Once registered, the attorney shall file a notice of appearance and ensure that s/he receives electronic notification of activity in this case. Also, the attorney shall ensure that the $150 admission fee be submitted to the Clerks Office. So Ordered by Magistrate Judge Anne Y. Shields on 3/31/2017. (Casalini, Rosalinde) (Entered: 03/31/2017) (0) |
Mar 30, 2017 | 25 | MOTION for Leave to Appear Pro Hac Vice Patrick C. Gallagher Filing fee $ 150, receipt number 0207-9410159. by Amneal Pharmaceuticals Co. GmbH, Amneal Pharmaceuticals LLC. (Attachments: # 1 Affidavit in Support of Motion to Admit Counsel PRO HAC VICE) (Gallagher, Patrick) (Entered: 03/30/2017) (0) |
Mar 29, 2017 | 26 | STIPULATION AND ORDER: THE PARTIES HEREBY STIPULATE AND AGREE, subject to the approval of the Court, as follows: 1. This case is STAYED for all purposes pending resolution of Amneal's Delaware motion and Teva's Delaware motion by the United States District Court for the District of Delaware. 2. Upon entry of this Stipulation as an Order of the Court, Amneal's request for a stay of proceedings pending resolution of Amneal's Delaware motion and Amneal's request for leave to move to transfer this action to the District of Delaware shall be deemed withdrawn. 3. The pre-motion conference scheduled for March 30, 2017, is ADJOURNED. 4. The parties will notify the Court of any decision on Amneal's Delaware motion or Teva's Delaware motion within five (5) business days. 5. In the event that Amneal's Delaware motion is granted or Teva's Delaware motion is denied, the parties will jointly request transfer of this action to the District of Delaware. 6. In the event that Amneal's Delaware motion is denied or Teva's Delaware motion is granted, no party will seek to transfer this case to any other jurisdiction, except that either party may seek transfer pursuant to 28 U.S.C. 1407 only for purposes of a multidistrict litigation proceeding concerning the '775 patent. 7. Neither party will refer to or rely on the other party's agreement to the foregoing stipulated stay of litigation in connection with any proceeding in this or any other action concerning any substantive or procedural aspect of this or any other case involving the parties. IT IS SO ORDERED by Judge Joan M. Azrack on 3/29/2017. (Case Stayed) (Ortiz, Grisel) (Entered: 03/31/2017) (4) |
Mar 29, 2017 | N/A | SCHEDULING ORDER: The pre-motion conference scheduled for March 30, 2017 is hereby adjourned. Ordered by Judge Joan M. Azrack on 3/29/2017. (Brachman, Lauren) (Entered: 03/29/2017) (0) |
Mar 29, 2017 | 24 | Letter MOTION to Adjourn Conference by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Stipulation and Proposed Order) (Holland, Elizabeth) (Entered: 03/29/2017) (0) |
Mar 28, 2017 | N/A | SCHEDULING ORDER: The parties are directed to jointly advise the Court whether they request a motion to stay this case pending decision on the motion to enjoin filed in the District of Delaware 22 . The parties are further directed to advise whether they wish to proceed with the pre-motion conference scheduled for March 30, 2017 at 11:30 AM. The parties are to respond to this Order by letter submitted by 5:00 PM on March 29, 2017. Ordered by Judge Joan M. Azrack on 3/28/2017. (Brachman, Lauren) (Entered: 03/28/2017) (0) |
Mar 24, 2017 | 23 | MOTION for Leave to Appear Pro Hac Vice Anthony J. Fitzpatrick Filing fee $ 150, receipt number 0207-9394436. by Amneal Pharmaceuticals Co. GmbH, Amneal Pharmaceuticals LLC. (Attachments: # 1 Affidavit in Support of Motion to Admit PRO HAC VICE, # 2 Certificate of Good Standing) (Fitzpatrick, Anthony) (Entered: 03/24/2017) (0) |
Mar 15, 2017 | 22 | Letter dated March 15, 2017 to the Honorable Joan M. Azrack In Response to Amneal's March 1 2017 Letter by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Hashmall, David) (Entered: 03/15/2017) (2) |
Mar 8, 2017 | 21 | NOTICE of Appearance by Nicholas K. Mitrokostas on behalf of Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (notification declined or already on case) (Mitrokostas, Nicholas) (Entered: 03/08/2017) (2) |
Mar 8, 2017 | 20 | NOTICE of Appearance by Brian T. Drummond on behalf of Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (notification declined or already on case) (Drummond, Brian) (Entered: 03/08/2017) (2) |
Mar 8, 2017 | 19 | NOTICE of Appearance by John T. Bennett on behalf of Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (notification declined or already on case) (Bennett, John) (Entered: 03/08/2017) (2) |
Mar 8, 2017 | 18 | NOTICE of Appearance by Daryl Wiesen on behalf of Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (notification declined or already on case) (Wiesen, Daryl) (Entered: 03/08/2017) (2) |
Mar 7, 2017 | N/A | Electronic ORDER granting 17 Motion for Leave to Appear Pro Hac Vice, Nicholas K. Mitrokostas for Plaintiffs Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Teva Neuroscience, Inc. The attorney shall register for ECF, registration is available online at the NYEDs homepage. Once registered, the attorney shall file a notice of appearance and ensure that s/he receives electronic notification of activity in this case. Also, the attorney shall ensure that the $150 admission fee be submitted to the Clerks Office. So Ordered by Magistrate Judge Anne Y. Shields on 3/7/2017. (Casalini, Rosalinde) (Entered: 03/07/2017) (0) |
Mar 7, 2017 | N/A | Electronic ORDER granting 16 Motion for Leave to Appear Pro Hac Vice, Brian T. Drummond for Plaintiffs Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Teva Neuroscience, Inc. The attorney shall register for ECF, registration is available online at the NYEDs homepage. Once registered, the attorney shall file a notice of appearance and ensure that s/he receives electronic notification of activity in this case. Also, the attorney shall ensure that the $150 admission fee be submitted to the Clerks Office. So Ordered by Magistrate Judge Anne Y. Shields on 3/7/2017. (Casalini, Rosalinde) (Entered: 03/07/2017) (0) |
Mar 7, 2017 | N/A | Electronic ORDER granting 15 Motion for Leave to Appear Pro Hac Vice, John T. Bennett for Plaintiffs Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Teva Neuroscience, Inc. The attorney shall register for ECF, registration is available online at the NYEDs homepage. Once registered, the attorney shall file a notice of appearance and ensure that s/he receives electronic notification of activity in this case. Also, the attorney shall ensure that the $150 admission fee be submitted to the Clerks Office. So Ordered by Magistrate Judge Anne Y. Shields on 3/7/2017. (Casalini, Rosalinde) (Entered: 03/07/2017) (0) |
Mar 7, 2017 | N/A | Electronic ORDER granting 14 Motion for Leave to Appear Pro Hac Vice, Daryl L. Wiesen for Plaintiffs Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Teva Neuroscience, Inc. The attorney shall register for ECF, registration is available online at the NYEDs homepage. Once registered, the attorney shall file a notice of appearance and ensure that s/he receives electronic notification of activity in this case. Also, the attorney shall ensure that the $150 admission fee be submitted to the Clerks Office. So Ordered by Magistrate Judge Anne Y. Shields on 3/7/2017. (Casalini, Rosalinde) (Entered: 03/07/2017) (0) |
Mar 3, 2017 | 17 | MOTION for Leave to Appear Pro Hac Vice Nicholas K. Mitrokostas Filing fee $ 150, receipt number 0207-9339997. by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit in Support, # 2 Proposed Order) (Mitrokostas, Nicholas) (Entered: 03/03/2017) (0) |
Mar 3, 2017 | 16 | MOTION for Leave to Appear Pro Hac Vice Brian T. Drummond Filing fee $ 150, receipt number 0207-9339980. by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit in Support, # 2 Proposed Order) (Drummond, Brian) (Entered: 03/03/2017) (0) |
Mar 3, 2017 | 15 | MOTION for Leave to Appear Pro Hac Vice John T. Bennett Filing fee $ 150, receipt number 0207-9339958. by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit in Support, # 2 Proposed Order) (Bennett, John) (Entered: 03/03/2017) (0) |
Mar 3, 2017 | 14 | MOTION for Leave to Appear Pro Hac Vice Daryl L. Wiesen Filing fee $ 150, receipt number 0207-9339939. by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit in Support, # 2 Proposed Order) (Wiesen, Daryl) (Entered: 03/03/2017) (0) |
Mar 1, 2017 | 13 | Letter MOTION to Stay this case pending a decision in the litigation in the District Court of Delaware and asks the Court address this request at the March 30th conference. by Amneal Pharmaceuticals Co. GmbH, Amneal Pharmaceuticals LLC. (Attachments: # 1 Exhibit A) (McQuillen, Brian) (Entered: 03/01/2017) (0) |
Mar 1, 2017 | 12 | NOTICE of Appearance by Brian McQuillen on behalf of Amneal Pharmaceuticals Co. GmbH (aty to be noticed) (McQuillen, Brian) (Entered: 03/01/2017) (1) |
Feb 28, 2017 | N/A | ORDER granting 9 Motion for Pre Motion Conference. A pre-motion conference will be held on 3/30/2017 at 11:30 AM before Judge Azrack in Courtroom 920 of the Long Island Courthouse. Ordered by Judge Joan M. Azrack on 2/28/2017. (Posillico, Lauren) (Entered: 02/28/2017) (0) |
Feb 18, 2017 | N/A | ORDER granting 11 Motion for Extension of Time to Answer re 11 Joint MOTION for Extension of Time to File Answer re 1 Complaint,, All Defendants. In light of the pending motion regarding the venue of this action, defendants are hereby granted until seven days after a decision is reached as to venue in which to answer or otherwise move with respect to the complaint. So Ordered by Magistrate Judge Anne Y. Shields on 2/18/2017. (Shields, Anne) (Entered: 02/18/2017) (0) |
Feb 17, 2017 | 11 | Joint MOTION for Extension of Time to File Answer re 1 Complaint,, by Amneal Pharmaceuticals LLC. (McQuillen, Brian) (Entered: 02/17/2017) (3) |
Feb 14, 2017 | N/A | Email Notification Test for Elizabeth Jean Holland - DO NOT REPLY (Entered: 02/14/2017) (0) |
Feb 13, 2017 | 10 | RESPONSE in Opposition re 9 Letter MOTION to Change Venue to the U.S. District Court for the District of Delaware filed by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 02/13/2017) (3) |
Feb 6, 2017 | 9 | Letter MOTION to for premotion conference to Change Venue to the U.S. District Court for the District of Delaware by Amneal Pharmaceuticals LLC. (McQuillen, Brian) Modified on 2/28/2017 (Posillico, Lauren). (Entered: 02/06/2017) (3) |
Feb 6, 2017 | N/A | Email Notification Test - DO NOT REPLY. (Latka-Mucha, Wieslawa) (Entered: 02/06/2017) (0) |
Feb 6, 2017 | 8 | NOTICE of Appearance by Brian McQuillen on behalf of Amneal Pharmaceuticals LLC (notification declined or already on case) (McQuillen, Brian) (Entered: 02/06/2017) (1) |
Feb 2, 2017 | 7 | SUMMONS Returned Executed by Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd.. Amneal Pharmaceuticals LLC served on 1/27/2017, answer due 2/17/2017. (Attachments: # 1 Affidavit of Service) (Hashmall, David) (Entered: 02/02/2017) (0) |
Jan 27, 2017 | 5 | AO120 Report on the Filing or Determination of an Action Regarding a Patent or (1) |
Jan 27, 2017 | 4 | Exhibit A (28) |
Jan 27, 2017 | 3 | Proposed Summons for Amneal Pharmaceuticals Co. GmbH (2) |
Jan 27, 2017 | 2 | Proposed Summons for Amneal Pharmaceuticals LLC (2) |
Jan 27, 2017 | 1 | Civil Cover Sheet (2) |
Jan 27, 2017 | 5 | AO120 Report on the Filing or Determination of an Action Regarding a Patent or (1) |
Jan 27, 2017 | 1 | Main Document (14) |
Jan 27, 2017 | 4 | Exhibit A (28) |
Jan 27, 2017 | 3 | Proposed Summons for Amneal Pharmaceuticals Co. GmbH (2) |
Jan 27, 2017 | 2 | Proposed Summons for Amneal Pharmaceuticals LLC (2) |
Jan 27, 2017 | 1 | Civil Cover Sheet (2) |
Jan 27, 2017 | 1 | Main Document (14) |
Jan 27, 2017 | 5 | AO120 Report on the Filing or Determination of an Action Regarding a Patent or (1) |
Jan 27, 2017 | 4 | Exhibit A (28) |
Jan 27, 2017 | 3 | Proposed Summons for Amneal Pharmaceuticals Co. GmbH (2) |
Jan 27, 2017 | 2 | Proposed Summons for Amneal Pharmaceuticals LLC (2) |
Jan 27, 2017 | 1 | Civil Cover Sheet (2) |
Jan 27, 2017 | 1 | Main Document (14) |
Jan 27, 2017 | 6 | Summons Issued as to Amneal Pharmaceuticals Co. GmbH. (Flanagan, Doreen) (Entered: 01/27/2017) (2) |
Jan 27, 2017 | N/A | This is a patent case and is eligible for the Patent Pilot Project. (Flanagan, Doreen) (Entered: 01/27/2017) (0) |
Jan 27, 2017 | N/A | Case Assigned to Judge Joan M. Azrack and Magistrate Judge Anne Y. Shields. Please download and review the Individual Practices of the assigned Judges, located on our website. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (Flanagan, Doreen) (Entered: 01/27/2017) (0) |